52
Belhaven Biopharma Inc. raises $32.3M under Reg D
Company raise · Closed · CHAPEL HILL, NC · Form D filed 2025-10-15
$10M+ raiseFirst raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Wes Algon Wheeler | Director |
| David Algon Neal | Chief Financial Officer and Secretary |
| Derek Algon Winstanly | Director |
| Scott David Lyman | President and Chief Executive Officer |
Signed by Scott David Lyman, President and Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.